Together, these results indicate that calcitriol suppresses AKT signaling in HER2-positive breast cancer cells, thereby potentially enhancing the antiproliferative efficacy of antiestrogens and tyrosine kinase inhibitors. Here, ERBB2 is linked to breast cancer.